思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01244 思路迪医药股份

未开盘 03-10 15:58:53

3.790

-0.010

-0.26%

最高3.880	最低3.590	成交量8.00万
今开3.600	昨收3.800	日振幅7.63%
总市值9.78亿	流通市值9.78亿	总股本2.58亿
成交额29.88万	换手率0.03%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"思路迪医药股份","latestPrice":3.79,"timestamp":1773129533504,"preClose":3.8,"halted":0,"volume":80000,"delay":0,"changeRate":-0.002631578947368365,"floatShares":258000000,"shares":258000000,"eps":-0.745688,"marketStatus":"未开盘","change":-0.01,"latestTime":"03-10 15:58:53","open":3.6,"high":3.88,"low":3.59,"amount":298815,"amplitude":0.076316,"askPrice":4.3,"askSize":5000,"bidPrice":3.8,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.716,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773192600000},"marketStatusCode":0,"adr":0,"listingDate":1671033600000,"exchange":"SEHK","adjPreClose":3.8,"openAndCloseTimeList":[[1773106200000,1773115200000],[1773118800000,1773129600000]],"volumeRatio":1.2307692305798816,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01244","defaultTab":"news","newsList":[{"id":"2617520124","title":"思路迪医药股份03月05日主力净流出17.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617520124?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:16","pubTimestamp":1772698568,"startTime":"0","endTime":"0","summary":"03月05日, 思路迪医药股份股价跌7.47%，报收3.47元，成交金额52.2万元，换手率0.06%，振幅8.27%，量比2.50。思路迪医药股份今日主力资金净流出17.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌16.99%，主力资金累计净流出17.4万元；近20日主力资金累计净流出34.9万元，其中净流出天数为2日。该股主力净额占比0.02%，港股市场排名2529/2716。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305162155a44eea9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305162155a44eea9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2616232909","title":"思路迪医药股份盘中异动 股价大跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616232909","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616232909?lang=zh_cn&edition=full","pubTime":"2026-03-03 14:32","pubTimestamp":1772519559,"startTime":"0","endTime":"0","summary":"2026年03月03日下午盘14时32分，思路迪医药股份股票出现异动，股价急速下跌6.47%。截至发稿，该股报3.900港元/股，成交量1.95万股，换手率0.01%，振幅4.80%。资金方面，该股资金流入2.075万港元，流出6.122万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。思路迪医药股份股票所在的生物技术行业中，整体跌幅为4.29%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303143239a69c2763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303143239a69c2763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2614049779","title":"思路迪医药股份盘中异动 下午盘快速拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614049779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614049779?lang=zh_cn&edition=full","pubTime":"2026-02-26 13:11","pubTimestamp":1772082660,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘13时11分，思路迪医药股份股票出现异动，股价急速拉升5.41%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为3.22%。其相关个股中，百奥赛图-B、思路迪医药股份、药捷安康-B涨幅较大，振幅较大的相关个股有三叶草生物-B、药捷安康-B、百奥赛图-B，振幅分别为11.96%、9.90%、9.28%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226131100a4c9fba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226131100a4c9fba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2613676503","title":"思路迪医药股份盘中异动 股价大跌7.44%报3.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613676503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613676503?lang=zh_cn&edition=full","pubTime":"2026-02-24 11:53","pubTimestamp":1771905205,"startTime":"0","endTime":"0","summary":"2026年02月24日临近午盘11时53分，思路迪医药股份股票出现波动，股价大幅下跌7.44%。截至发稿，该股报3.610港元/股，成交量4.55万股，换手率0.02%，振幅7.44%。资金方面，该股资金流入0港元，流出16.667万港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为3.29%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022411532597a6ca2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022411532597a6ca2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2610651658","title":"思路迪医药股份(01244)：恩维达®附条件批准转常规批准补充申请获NMPA正式受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651658","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610651658?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:58","pubTimestamp":1770649080,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份 公布，恩维达 由附条件批准转为常规批准的境内生产药品补充申请，正式获得国家药品监督管理局 受理，受理号为CYSB2600056，申请规格为200mg╱瓶。本次申请由公司旗下四川思路康瑞药业有限公司提交，申报材料于2026年2月2日完成签收并经审查予以受理。根据该协议，江苏先声获授予恩维达于中国大陆内的肿瘤适应症的独家市场推广权及对外许可或转让下的优先受让权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"思路迪医药股份(01244)：恩维达®附条件批准转常规批准补充申请获NMPA正式受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1114583071","title":"思路迪医药股份：恩沃利单抗补充申请获国家药监局受理，有条件批准向常规批准转换","url":"https://stock-news.laohu8.com/highlight/detail?id=1114583071","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114583071?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:55","pubTimestamp":1770648927,"startTime":"0","endTime":"0","summary":"思路迪医药股份宣布，其核心产品恩沃利单抗（Envafolimab）的补充申请已获得国家药品监督管理局（NMPA）正式受理。此次申请旨在推动该药物从有条件批准向常规批准过渡，标志着公司在新药审批进程中迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2609396029","title":"思路迪医药股份盘中异动 下午盘大幅下挫7.58%报4.270港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609396029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609396029?lang=zh_cn&edition=full","pubTime":"2026-02-04 14:24","pubTimestamp":1770186249,"startTime":"0","endTime":"0","summary":"2026年02月04日下午盘14时24分，思路迪医药股份股票出现波动，股价急速跳水7.58%。截至发稿，该股报4.270港元/股，成交量2.3万股，换手率0.01%，振幅7.58%。资金方面，该股资金流入5.2755万港元，流出3.4415万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为2.02%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204142410953fbed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204142410953fbed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2608840173","title":"思路迪医药股份盘中异动 大幅下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608840173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608840173?lang=zh_cn&edition=full","pubTime":"2026-02-03 13:25","pubTimestamp":1770096354,"startTime":"0","endTime":"0","summary":"2026年02月03日下午盘13时25分，思路迪医药股份股票出现波动，股价快速跳水5.26%。截至发稿，该股报4.500港元/股，成交量7.5万股，换手率0.03%，振幅5.26%。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.62%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203132554953f8e32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203132554953f8e32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2608989800","title":"思路迪医药股份盘中异动 股价大涨5.26%报5.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608989800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608989800?lang=zh_cn&edition=full","pubTime":"2026-02-02 09:34","pubTimestamp":1769996085,"startTime":"0","endTime":"0","summary":"2026年02月02日早盘09时34分，思路迪医药股份股票出现波动，股价急速上涨5.26%。截至发稿，该股报5.000港元/股，成交量9500股，换手率0.00%，振幅6.32%。资金方面，该股资金流入4.04万港元，流出0港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，思路迪医药股份、同源康医药-B、嘉和生物涨幅较大，振幅较大的相关个股有MIRXES-B、荣昌生物、思路迪医药股份，振幅分别为7.60%、6.41%、6.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202093446a4710eba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202093446a4710eba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2606221771","title":"思路迪医药股份盘中异动 早盘股价大跌5.81%报4.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606221771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606221771?lang=zh_cn&edition=full","pubTime":"2026-01-26 11:02","pubTimestamp":1769396565,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘11时02分，思路迪医药股份股票出现异动，股价急速下跌5.81%。截至发稿，该股报4.700港元/股，成交量11.4万股，换手率0.04%，振幅7.82%。资金方面，该股资金流入2545港元，流出54.4935万港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.76%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126110246a45598f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126110246a45598f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2605416857","title":"思路迪医药股份盘中异动 快速下跌6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416857?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:33","pubTimestamp":1769067232,"startTime":"0","endTime":"0","summary":"2026年01月22日临近收盘15时33分，思路迪医药股份股票出现波动，股价快速下跌6.77%。截至发稿，该股报4.820港元/股，成交量9.7万股，换手率0.04%，振幅6.96%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.56%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122153352953ddb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122153352953ddb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2605485662","title":"思路迪医药股份盘中异动 大幅拉升6.92%报5.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605485662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605485662?lang=zh_cn&edition=full","pubTime":"2026-01-21 14:12","pubTimestamp":1768975971,"startTime":"0","endTime":"0","summary":"2026年01月21日下午盘14时12分，思路迪医药股份股票出现波动，股价快速上涨6.92%。截至发稿，该股报5.560港元/股，成交量2.6万股，换手率0.01%，振幅6.92%。资金方面，该股资金流入3.424万港元，流出9.3775万港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.00%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012114125197a2b564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012114125197a2b564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2604404118","title":"思路迪医药股份盘中异动 早盘股价大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604404118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604404118?lang=zh_cn&edition=full","pubTime":"2026-01-20 10:35","pubTimestamp":1768876551,"startTime":"0","endTime":"0","summary":"2026年01月20日早盘10时35分，思路迪医药股份股票出现异动，股价急速下跌6.35%。截至发稿，该股报5.160港元/股，成交量1.8万股，换手率0.01%，振幅6.35%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为2.14%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120103551a43f017e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120103551a43f017e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2603779938","title":"思路迪医药股份盘中异动 股价大跌5.56%报5.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603779938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603779938?lang=zh_cn&edition=full","pubTime":"2026-01-15 10:37","pubTimestamp":1768444664,"startTime":"0","endTime":"0","summary":"2026年01月15日早盘10时37分，思路迪医药股份股票出现异动，股价急速下跌5.56%。截至发稿，该股报5.600港元/股，成交量9500股，换手率0.00%，振幅5.40%。资金方面，该股资金流入5880港元，流出4.94万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.63%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011510374497a1e0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011510374497a1e0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2602543046","title":"思路迪医药股份(01244)委任陆孝皓为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543046","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602543046?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:03","pubTimestamp":1768226594,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)公布，张竞女士已正式辞去公司首席财务官职务;陆孝皓先生已获任命为首席财务官，上述任命即日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2602716213","title":"思路迪医药股份(01244)：恩维达®一线胆道癌新药上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2602716213","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602716213?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:05","pubTimestamp":1767967506,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)发布公告，国家药品监督管理局(NMPA)已正式受理公司商业化产品恩维达® (通用名：恩沃利单抗注射液，原研代号：KN035)联合吉西他滨和奥沙利铂(GEMOX)方案，用于一线治疗不可切除或转移性胆道癌 (BTC)的新药上市申请(NDA)。此次受理基于III期临床试验(KN035-CN-005)的临床研究结果，这是一项针对中国晚期一线胆道癌患者设计的随机、平行对照、多中心III期临床试验，旨在评估恩维达®(KN035)联合GEMOX方案对比单纯GEMOX方案的疗效与安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"思路迪医药股份(01244)：恩维达®一线胆道癌新药上市申请获国家药监局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2602134108","title":"思路迪医药股份盘中异动 急速上涨6.08%报5.580港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602134108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602134108?lang=zh_cn&edition=full","pubTime":"2026-01-09 10:15","pubTimestamp":1767924914,"startTime":"0","endTime":"0","summary":"2026年01月09日早盘10时15分，思路迪医药股份股票出现异动，股价急速拉升6.08%。截至发稿，该股报5.580港元/股，成交量7.4万股，换手率0.03%，振幅6.46%。资金方面，该股资金流入39.4655万港元，流出5315港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，瑞博生物-B、博安生物、思路迪医药股份涨幅较大，振幅较大的相关个股有拨康视云-B、瑞博生物-B、博安生物，振幅分别为19.19%、16.47%、9.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109101514953c4200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109101514953c4200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2600064872","title":"思路迪医药股份盘中异动 早盘大幅下挫6.00%报5.010港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600064872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600064872?lang=zh_cn&edition=full","pubTime":"2026-01-02 10:06","pubTimestamp":1767319585,"startTime":"0","endTime":"0","summary":"2026年01月02日早盘10时06分，思路迪医药股份股票出现波动，股价急速下跌6.00%。截至发稿，该股报5.010港元/股，成交量2.05万股，换手率0.01%，振幅0.38%。资金方面，该股资金流入0港元，流出10.2995万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，帝王国际投资、云康集团、中国抗体-B涨幅较大，振幅较大的相关个股有科笛-B、北海康成-B、轩竹生物-B，振幅分别为11.01%、9.77%、9.29%。该公司主要在中国国内市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102100625953be67a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102100625953be67a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2593464505","title":"思路迪医药股份(01244.HK)涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593464505","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593464505?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:14","pubTimestamp":1766470491,"startTime":"0","endTime":"0","summary":"每经AI快讯，思路迪医药股份(01244.HK)涨近7%，截至发稿涨6.77%，报4.73港元，成交额91.12万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599400621.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599400621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2593043352","title":"思路迪医药股份(01244)：恩维达®胃癌和胃食管结合部癌适应症获孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2593043352","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593043352?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:12","pubTimestamp":1766412751,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)发布公告，旗下商业化产品恩维达® (通用名：恩沃利单抗注射液，原研代号：KN035)针对胃癌和胃食管结合部癌适应症正式获得孤儿药资格认定，这是恩维达®继胆管癌和软组织肉瘤适应症后成功获批的第叁个孤儿药适应症。此次获批基于本公司开展的恩维达®晚期胃/食管胃结合部腺癌的II期临床研究展现出明确的抗肿瘤疗效，其联合FOLFOX方案的客观缓解率达60%，疾病控制率高达100%，且安全性与耐受性良好，无导致治疗终止或死亡的不良事件发生。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01244"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3d-medicines.com","stockEarnings":[{"period":"1week","weight":-0.0332},{"period":"1month","weight":-0.1521},{"period":"3month","weight":-0.251},{"period":"6month","weight":-0.5821},{"period":"1year","weight":0.2935},{"period":"ytd","weight":-0.2889}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":-0.0226},{"period":"3month","weight":0.0164},{"period":"6month","weight":-0.0048},{"period":"1year","weight":0.0915},{"period":"ytd","weight":0.0129}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。该公司专注于肿瘤慢病化治疗领域的创新药物发现、开发及商业化，同时布局肿瘤疼痛管理领域。该公司已经构建一套完整的公司内部研发体系，已实现了从药物发现，临床前开发，临床试验、注册的全流程覆盖。该公司第一款上市药物恩维达是一款用于治疗泛瘤种的皮下注射PD-L1抑制剂。该公司还拥有多项创新药研发管线。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.034607},{"month":2,"riseRate":0.75,"avgChangeRate":0.110633},{"month":3,"riseRate":0.25,"avgChangeRate":0.023423},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.025133},{"month":5,"riseRate":0.666667,"avgChangeRate":0.093531},{"month":6,"riseRate":0.333333,"avgChangeRate":0.03295},{"month":7,"riseRate":0.333333,"avgChangeRate":0.019677},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.195829},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.13358},{"month":10,"riseRate":0,"avgChangeRate":-0.260453},{"month":11,"riseRate":0,"avgChangeRate":-0.194469},{"month":12,"riseRate":0.666667,"avgChangeRate":0.250685}],"exchange":"SEHK","name":"思路迪医药股份","nameEN":"3D MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"思路迪医药股份,01244,思路迪医药股份股票,思路迪医药股份股票老虎,思路迪医药股份股票老虎国际,思路迪医药股份行情,思路迪医药股份股票行情,思路迪医药股份股价,思路迪医药股份股市,思路迪医药股份股票价格,思路迪医药股份股票交易,思路迪医药股份股票购买,思路迪医药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}